Pharma & Healthcare
Global Neglected Tropical Diseases Drugs and Vaccine Market Research Report 2024
- Jan 29, 24
- ID: 49471
- Pages: 83
- Figures: 162
- Views: 15
Neglected tropical diseases (NTDs) are a diverse group of tropical infections which are common in low-income populations in developing regions of Africa, Asia, and the Americas. They are caused by a variety of pathogens such as viruses, bacteria, protozoa and helminths.
The global Neglected Tropical Diseases Drugs and Vaccine market was valued at US$ 345 million in 2023 and is anticipated to reach US$ 474.1 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
The Neglected Tropical Diseases (NTDs) Drugs and Vaccine Market is driven by the pressing need to combat and eradicate diseases that predominantly affect marginalized and underserved populations in tropical regions. NTDs, which include diseases like malaria, dengue, and schistosomiasis, cause significant morbidity and mortality, making it imperative to develop treatments and vaccines. As global health initiatives and pharmaceutical companies focus on addressing NTDs, the demand for research, development, and access to effective drugs and vaccines continues to grow. However, a key challenge for this market is the need to overcome financial and regulatory hurdles that often hinder investment in NTD research and drug development. Ensuring equitable access to these treatments, addressing drug resistance, and overcoming logistic challenges in delivering vaccines to remote areas are ongoing obstacles. Additionally, the market faces competition from other health priorities and diseases, requiring sustained efforts to mobilize resources and global commitment to eliminate NTDs. Striking a balance between innovation, affordability, and accessibility while addressing the unique challenges of NTDs is crucial for the continued progress of the Neglected Tropical Diseases Drugs and Vaccine Market.
This report aims to provide a comprehensive presentation of the global market for Neglected Tropical Diseases Drugs and Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neglected Tropical Diseases Drugs and Vaccine.
Report Scope
The Neglected Tropical Diseases Drugs and Vaccine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neglected Tropical Diseases Drugs and Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neglected Tropical Diseases Drugs and Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Artecef BV
GlaxoSmithKline
AstraZeneca
Novartis
Sanofi-Aventis
Ranbaxy Labs
Lupin
Macleods Pharmaceuticals
Cipla
Romark Laboratories
Toyama Chemica
Segment by Type
Malaria
Ebola
Dengue
Chagas
Leishmaniasis
Other
Segment by Application
Drugs
Vaccines
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neglected Tropical Diseases Drugs and Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Neglected Tropical Diseases Drugs and Vaccine market was valued at US$ 345 million in 2023 and is anticipated to reach US$ 474.1 million by 2030, witnessing a CAGR of 4.6% during the forecast period 2024-2030.
The Neglected Tropical Diseases (NTDs) Drugs and Vaccine Market is driven by the pressing need to combat and eradicate diseases that predominantly affect marginalized and underserved populations in tropical regions. NTDs, which include diseases like malaria, dengue, and schistosomiasis, cause significant morbidity and mortality, making it imperative to develop treatments and vaccines. As global health initiatives and pharmaceutical companies focus on addressing NTDs, the demand for research, development, and access to effective drugs and vaccines continues to grow. However, a key challenge for this market is the need to overcome financial and regulatory hurdles that often hinder investment in NTD research and drug development. Ensuring equitable access to these treatments, addressing drug resistance, and overcoming logistic challenges in delivering vaccines to remote areas are ongoing obstacles. Additionally, the market faces competition from other health priorities and diseases, requiring sustained efforts to mobilize resources and global commitment to eliminate NTDs. Striking a balance between innovation, affordability, and accessibility while addressing the unique challenges of NTDs is crucial for the continued progress of the Neglected Tropical Diseases Drugs and Vaccine Market.
This report aims to provide a comprehensive presentation of the global market for Neglected Tropical Diseases Drugs and Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neglected Tropical Diseases Drugs and Vaccine.
Report Scope
The Neglected Tropical Diseases Drugs and Vaccine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neglected Tropical Diseases Drugs and Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neglected Tropical Diseases Drugs and Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Artecef BV
GlaxoSmithKline
AstraZeneca
Novartis
Sanofi-Aventis
Ranbaxy Labs
Lupin
Macleods Pharmaceuticals
Cipla
Romark Laboratories
Toyama Chemica
Segment by Type
Malaria
Ebola
Dengue
Chagas
Leishmaniasis
Other
Segment by Application
Drugs
Vaccines
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neglected Tropical Diseases Drugs and Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Malaria
1.2.3 Ebola
1.2.4 Dengue
1.2.5 Chagas
1.2.6 Leishmaniasis
1.2.7 Other
1.3 Market by Application
1.3.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drugs
1.3.3 Vaccines
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Perspective (2019-2030)
2.2 Neglected Tropical Diseases Drugs and Vaccine Growth Trends by Region
2.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Region (2019-2024)
2.2.3 Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Region (2025-2030)
2.3 Neglected Tropical Diseases Drugs and Vaccine Market Dynamics
2.3.1 Neglected Tropical Diseases Drugs and Vaccine Industry Trends
2.3.2 Neglected Tropical Diseases Drugs and Vaccine Market Drivers
2.3.3 Neglected Tropical Diseases Drugs and Vaccine Market Challenges
2.3.4 Neglected Tropical Diseases Drugs and Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue
3.1.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue (2019-2024)
3.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Players (2019-2024)
3.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neglected Tropical Diseases Drugs and Vaccine Revenue
3.4 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio
3.4.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2023
3.5 Neglected Tropical Diseases Drugs and Vaccine Key Players Head office and Area Served
3.6 Key Players Neglected Tropical Diseases Drugs and Vaccine Product Solution and Service
3.7 Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Type
4.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Type (2019-2024)
4.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2025-2030)
5 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Application
5.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Application (2019-2024)
5.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size (2019-2030)
6.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2019-2024)
6.4 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (2019-2030)
7.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2019-2024)
7.4 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size (2019-2030)
8.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2019-2024)
8.4 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size (2019-2030)
9.2 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2019-2024)
9.4 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (2019-2030)
10.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2019-2024)
10.4 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Artecef BV
11.1.1 Artecef BV Company Detail
11.1.2 Artecef BV Business Overview
11.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Introduction
11.1.4 Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.1.5 Artecef BV Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Introduction
11.2.4 GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.2.5 GlaxoSmithKline Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Introduction
11.3.4 AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.3.5 AstraZeneca Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Introduction
11.4.4 Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Sanofi-Aventis
11.5.1 Sanofi-Aventis Company Detail
11.5.2 Sanofi-Aventis Business Overview
11.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Introduction
11.5.4 Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.5.5 Sanofi-Aventis Recent Development
11.6 Ranbaxy Labs
11.6.1 Ranbaxy Labs Company Detail
11.6.2 Ranbaxy Labs Business Overview
11.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Introduction
11.6.4 Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.6.5 Ranbaxy Labs Recent Development
11.7 Lupin
11.7.1 Lupin Company Detail
11.7.2 Lupin Business Overview
11.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Introduction
11.7.4 Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.7.5 Lupin Recent Development
11.8 Macleods Pharmaceuticals
11.8.1 Macleods Pharmaceuticals Company Detail
11.8.2 Macleods Pharmaceuticals Business Overview
11.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Introduction
11.8.4 Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.8.5 Macleods Pharmaceuticals Recent Development
11.9 Cipla
11.9.1 Cipla Company Detail
11.9.2 Cipla Business Overview
11.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Introduction
11.9.4 Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.9.5 Cipla Recent Development
11.10 Romark Laboratories
11.10.1 Romark Laboratories Company Detail
11.10.2 Romark Laboratories Business Overview
11.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Introduction
11.10.4 Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.10.5 Romark Laboratories Recent Development
11.11 Toyama Chemica
11.11.1 Toyama Chemica Company Detail
11.11.2 Toyama Chemica Business Overview
11.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Introduction
11.11.4 Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.11.5 Toyama Chemica Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Malaria
1.2.3 Ebola
1.2.4 Dengue
1.2.5 Chagas
1.2.6 Leishmaniasis
1.2.7 Other
1.3 Market by Application
1.3.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drugs
1.3.3 Vaccines
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Perspective (2019-2030)
2.2 Neglected Tropical Diseases Drugs and Vaccine Growth Trends by Region
2.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Region (2019-2024)
2.2.3 Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Region (2025-2030)
2.3 Neglected Tropical Diseases Drugs and Vaccine Market Dynamics
2.3.1 Neglected Tropical Diseases Drugs and Vaccine Industry Trends
2.3.2 Neglected Tropical Diseases Drugs and Vaccine Market Drivers
2.3.3 Neglected Tropical Diseases Drugs and Vaccine Market Challenges
2.3.4 Neglected Tropical Diseases Drugs and Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue
3.1.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue (2019-2024)
3.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Players (2019-2024)
3.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neglected Tropical Diseases Drugs and Vaccine Revenue
3.4 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio
3.4.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2023
3.5 Neglected Tropical Diseases Drugs and Vaccine Key Players Head office and Area Served
3.6 Key Players Neglected Tropical Diseases Drugs and Vaccine Product Solution and Service
3.7 Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Type
4.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Type (2019-2024)
4.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2025-2030)
5 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Application
5.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Application (2019-2024)
5.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size (2019-2030)
6.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2019-2024)
6.4 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (2019-2030)
7.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2019-2024)
7.4 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size (2019-2030)
8.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2019-2024)
8.4 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size (2019-2030)
9.2 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2019-2024)
9.4 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (2019-2030)
10.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2019-2024)
10.4 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Artecef BV
11.1.1 Artecef BV Company Detail
11.1.2 Artecef BV Business Overview
11.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Introduction
11.1.4 Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.1.5 Artecef BV Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Introduction
11.2.4 GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.2.5 GlaxoSmithKline Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Introduction
11.3.4 AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.3.5 AstraZeneca Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Introduction
11.4.4 Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Sanofi-Aventis
11.5.1 Sanofi-Aventis Company Detail
11.5.2 Sanofi-Aventis Business Overview
11.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Introduction
11.5.4 Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.5.5 Sanofi-Aventis Recent Development
11.6 Ranbaxy Labs
11.6.1 Ranbaxy Labs Company Detail
11.6.2 Ranbaxy Labs Business Overview
11.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Introduction
11.6.4 Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.6.5 Ranbaxy Labs Recent Development
11.7 Lupin
11.7.1 Lupin Company Detail
11.7.2 Lupin Business Overview
11.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Introduction
11.7.4 Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.7.5 Lupin Recent Development
11.8 Macleods Pharmaceuticals
11.8.1 Macleods Pharmaceuticals Company Detail
11.8.2 Macleods Pharmaceuticals Business Overview
11.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Introduction
11.8.4 Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.8.5 Macleods Pharmaceuticals Recent Development
11.9 Cipla
11.9.1 Cipla Company Detail
11.9.2 Cipla Business Overview
11.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Introduction
11.9.4 Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.9.5 Cipla Recent Development
11.10 Romark Laboratories
11.10.1 Romark Laboratories Company Detail
11.10.2 Romark Laboratories Business Overview
11.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Introduction
11.10.4 Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.10.5 Romark Laboratories Recent Development
11.11 Toyama Chemica
11.11.1 Toyama Chemica Company Detail
11.11.2 Toyama Chemica Business Overview
11.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Introduction
11.11.4 Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
11.11.5 Toyama Chemica Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Malaria
Table 3. Key Players of Ebola
Table 4. Key Players of Dengue
Table 5. Key Players of Chagas
Table 6. Key Players of Leishmaniasis
Table 7. Key Players of Other
Table 8. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2019-2024)
Table 12. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2025-2030)
Table 14. Neglected Tropical Diseases Drugs and Vaccine Market Trends
Table 15. Neglected Tropical Diseases Drugs and Vaccine Market Drivers
Table 16. Neglected Tropical Diseases Drugs and Vaccine Market Challenges
Table 17. Neglected Tropical Diseases Drugs and Vaccine Market Restraints
Table 18. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Players (2019-2024)
Table 20. Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2023)
Table 21. Ranking of Global Top Neglected Tropical Diseases Drugs and Vaccine Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Neglected Tropical Diseases Drugs and Vaccine Product Solution and Service
Table 25. Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2019-2024)
Table 29. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2025-2030)
Table 31. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2019-2024)
Table 33. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2025-2030)
Table 35. North America Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 50. Artecef BV Company Detail
Table 51. Artecef BV Business Overview
Table 52. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product
Table 53. Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 54. Artecef BV Recent Development
Table 55. GlaxoSmithKline Company Detail
Table 56. GlaxoSmithKline Business Overview
Table 57. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product
Table 58. GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 59. GlaxoSmithKline Recent Development
Table 60. AstraZeneca Company Detail
Table 61. AstraZeneca Business Overview
Table 62. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product
Table 63. AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 64. AstraZeneca Recent Development
Table 65. Novartis Company Detail
Table 66. Novartis Business Overview
Table 67. Novartis Neglected Tropical Diseases Drugs and Vaccine Product
Table 68. Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 69. Novartis Recent Development
Table 70. Sanofi-Aventis Company Detail
Table 71. Sanofi-Aventis Business Overview
Table 72. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product
Table 73. Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 74. Sanofi-Aventis Recent Development
Table 75. Ranbaxy Labs Company Detail
Table 76. Ranbaxy Labs Business Overview
Table 77. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product
Table 78. Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 79. Ranbaxy Labs Recent Development
Table 80. Lupin Company Detail
Table 81. Lupin Business Overview
Table 82. Lupin Neglected Tropical Diseases Drugs and Vaccine Product
Table 83. Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 84. Lupin Recent Development
Table 85. Macleods Pharmaceuticals Company Detail
Table 86. Macleods Pharmaceuticals Business Overview
Table 87. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product
Table 88. Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 89. Macleods Pharmaceuticals Recent Development
Table 90. Cipla Company Detail
Table 91. Cipla Business Overview
Table 92. Cipla Neglected Tropical Diseases Drugs and Vaccine Product
Table 93. Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 94. Cipla Recent Development
Table 95. Romark Laboratories Company Detail
Table 96. Romark Laboratories Business Overview
Table 97. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product
Table 98. Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 99. Romark Laboratories Recent Development
Table 100. Toyama Chemica Company Detail
Table 101. Toyama Chemica Business Overview
Table 102. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product
Table 103. Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 104. Toyama Chemica Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Type: 2023 VS 2030
Figure 3. Malaria Features
Figure 4. Ebola Features
Figure 5. Dengue Features
Figure 6. Chagas Features
Figure 7. Leishmaniasis Features
Figure 8. Other Features
Figure 9. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application: 2023 VS 2030
Figure 11. Drugs Case Studies
Figure 12. Vaccines Case Studies
Figure 13. Neglected Tropical Diseases Drugs and Vaccine Report Years Considered
Figure 14. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Neglected Tropical Diseases Drugs and Vaccine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region: 2023 VS 2030
Figure 17. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Players in 2023
Figure 18. Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2023
Figure 20. North America Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2019-2030)
Figure 22. United States Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2019-2030)
Figure 26. Germany Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2019-2030)
Figure 34. China Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2019-2030)
Figure 42. Mexico Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2019-2030)
Figure 46. Turkey Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Artecef BV Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 49. GlaxoSmithKline Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 50. AstraZeneca Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 51. Novartis Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 52. Sanofi-Aventis Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 53. Ranbaxy Labs Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 54. Lupin Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 55. Macleods Pharmaceuticals Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 56. Cipla Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 57. Romark Laboratories Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 58. Toyama Chemica Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Malaria
Table 3. Key Players of Ebola
Table 4. Key Players of Dengue
Table 5. Key Players of Chagas
Table 6. Key Players of Leishmaniasis
Table 7. Key Players of Other
Table 8. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2019-2024)
Table 12. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2025-2030)
Table 14. Neglected Tropical Diseases Drugs and Vaccine Market Trends
Table 15. Neglected Tropical Diseases Drugs and Vaccine Market Drivers
Table 16. Neglected Tropical Diseases Drugs and Vaccine Market Challenges
Table 17. Neglected Tropical Diseases Drugs and Vaccine Market Restraints
Table 18. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Players (2019-2024)
Table 20. Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2023)
Table 21. Ranking of Global Top Neglected Tropical Diseases Drugs and Vaccine Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Neglected Tropical Diseases Drugs and Vaccine Product Solution and Service
Table 25. Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2019-2024)
Table 29. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2025-2030)
Table 31. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2019-2024)
Table 33. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2025-2030)
Table 35. North America Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2025-2030) & (US$ Million)
Table 50. Artecef BV Company Detail
Table 51. Artecef BV Business Overview
Table 52. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product
Table 53. Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 54. Artecef BV Recent Development
Table 55. GlaxoSmithKline Company Detail
Table 56. GlaxoSmithKline Business Overview
Table 57. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product
Table 58. GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 59. GlaxoSmithKline Recent Development
Table 60. AstraZeneca Company Detail
Table 61. AstraZeneca Business Overview
Table 62. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product
Table 63. AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 64. AstraZeneca Recent Development
Table 65. Novartis Company Detail
Table 66. Novartis Business Overview
Table 67. Novartis Neglected Tropical Diseases Drugs and Vaccine Product
Table 68. Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 69. Novartis Recent Development
Table 70. Sanofi-Aventis Company Detail
Table 71. Sanofi-Aventis Business Overview
Table 72. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product
Table 73. Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 74. Sanofi-Aventis Recent Development
Table 75. Ranbaxy Labs Company Detail
Table 76. Ranbaxy Labs Business Overview
Table 77. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product
Table 78. Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 79. Ranbaxy Labs Recent Development
Table 80. Lupin Company Detail
Table 81. Lupin Business Overview
Table 82. Lupin Neglected Tropical Diseases Drugs and Vaccine Product
Table 83. Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 84. Lupin Recent Development
Table 85. Macleods Pharmaceuticals Company Detail
Table 86. Macleods Pharmaceuticals Business Overview
Table 87. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product
Table 88. Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 89. Macleods Pharmaceuticals Recent Development
Table 90. Cipla Company Detail
Table 91. Cipla Business Overview
Table 92. Cipla Neglected Tropical Diseases Drugs and Vaccine Product
Table 93. Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 94. Cipla Recent Development
Table 95. Romark Laboratories Company Detail
Table 96. Romark Laboratories Business Overview
Table 97. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product
Table 98. Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 99. Romark Laboratories Recent Development
Table 100. Toyama Chemica Company Detail
Table 101. Toyama Chemica Business Overview
Table 102. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product
Table 103. Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024) & (US$ Million)
Table 104. Toyama Chemica Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Type: 2023 VS 2030
Figure 3. Malaria Features
Figure 4. Ebola Features
Figure 5. Dengue Features
Figure 6. Chagas Features
Figure 7. Leishmaniasis Features
Figure 8. Other Features
Figure 9. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application: 2023 VS 2030
Figure 11. Drugs Case Studies
Figure 12. Vaccines Case Studies
Figure 13. Neglected Tropical Diseases Drugs and Vaccine Report Years Considered
Figure 14. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Neglected Tropical Diseases Drugs and Vaccine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region: 2023 VS 2030
Figure 17. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Players in 2023
Figure 18. Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2023
Figure 20. North America Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2019-2030)
Figure 22. United States Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2019-2030)
Figure 26. Germany Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2019-2030)
Figure 34. China Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2019-2030)
Figure 42. Mexico Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2019-2030)
Figure 46. Turkey Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Artecef BV Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 49. GlaxoSmithKline Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 50. AstraZeneca Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 51. Novartis Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 52. Sanofi-Aventis Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 53. Ranbaxy Labs Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 54. Lupin Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 55. Macleods Pharmaceuticals Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 56. Cipla Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 57. Romark Laboratories Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 58. Toyama Chemica Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232